(Q33902418)

29 July 2017

Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin (English)

1 reference

29 July 2017

Lahiri DK

1

1 reference

29 July 2017

Ge YW

series ordinal

2

1 reference

29 July 2017

Farlow MR

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Annals of the New York Academy of Sciences

29 July 2017

1 reference

29 July 2017

903

1 reference

29 July 2017

387-393

1 reference

Alzheimer's disease: genotypes, phenotypes, and treatments

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

Membrane trafficking in the presynaptic nerve terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

AIT-082 as a potential neuroprotective and regenerative agent in stroke and central nervous system injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

Distinct domains of syntaxin are required for synaptic vesicle fusion complex formation and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

Specificity and regulation of a synaptic vesicle docking complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06390.X

10.1111/J.1749-6632.2000.TB06390.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference